
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Pharmacol. , 24 January 2019
Sec. Experimental Pharmacology and Drug Discovery
Volume 9 - 2018 | https://doi.org/10.3389/fphar.2018.01558
This article is part of the Research Topic Novel Targets and Biomarkers in Solid Tumors View all 32 articles
A retraction of this article was approved in:
Retraction: DEAD-Box Helicase 5 Interacts With Transcription Factor 12 and Promotes the Progression of Osteosarcoma by Stimulating Cell Cycle Progression
Citation: Chen Y, Wang Q, Wang Q, Liu J, Jiang X, Zhang Y, Liu Y, Zhou F and Liu H (2019) DEAD-Box Helicase 5 Interacts With Transcription Factor 12 and Promotes the Progression of Osteosarcoma by Stimulating Cell Cycle Progression. Front. Pharmacol. 9:1558. doi: 10.3389/fphar.2018.01558
Received: 08 November 2018; Accepted: 21 December 2018;
Published: 24 January 2019; Retracted: 23 December 2019.
Edited by:
Dong-Hua Yang, St. John’s University, United StatesReviewed by:
Bo Tian, National Tsing Hua University, TaiwanDisclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.